Literature DB >> 17010455

Recognition of the tumor suppressor protein p53 and other protein targets by the calcium-binding protein S100B.

Paul T Wilder1, Jing Lin, Catherine L Bair, Thomas H Charpentier, Dong Yang, Melissa Liriano, Kristen M Varney, Andrew Lee, Amos B Oppenheim, Sankar Adhya, France Carrier, David J Weber.   

Abstract

S100B is an EF-hand containing calcium-binding protein of the S100 protein family that exerts its biological effect by binding and affecting various target proteins. A consensus sequence for S100B target proteins was published as (K/R)(L/I)xWxxIL and matches a region in the actin capping protein CapZ (V.V. Ivanenkov, G.A. Jamieson, Jr., E. Gruenstein, R.V. Dimlich, Characterization of S-100b binding epitopes. Identification of a novel target, the actin capping protein, CapZ, J. Biol. Chem. 270 (1995) 14651-14658). Several additional S100B targets are known including p53, a nuclear Dbf2 related (NDR) kinase, the RAGE receptor, neuromodulin, protein kinase C, and others. Examining the binding sites of such targets and new protein sequence searches provided additional potential target proteins for S100B including Hdm2 and Hdm4, which were both found to bind S100B in a calcium-dependent manner. The interaction between S100B and the Hdm2 and/or the Hdm4 proteins may be important physiologically in light of evidence that like Hdm2, S100B also contributes to lowering protein levels of the tumor suppressor protein, p53. For the S100B-p53 interaction, it was found that phosphorylation of specific serine and/or threonine residues reduces the affinity of the S100B-p53 interaction by as much as an order of magnitude, and is important for protecting p53 from S100B-dependent down-regulation, a scenario that is similar to what is found for the Hdm2-p53 complex.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17010455     DOI: 10.1016/j.bbamcr.2006.08.024

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  43 in total

1.  The calcium-dependent interaction between S100B and the mitochondrial AAA ATPase ATAD3A and the role of this complex in the cytoplasmic processing of ATAD3A.

Authors:  Benoît Gilquin; Brian R Cannon; Arnaud Hubstenberger; Boualem Moulouel; Elin Falk; Nicolas Merle; Nicole Assard; Sylvie Kieffer; Denis Rousseau; Paul T Wilder; David J Weber; Jacques Baudier
Journal:  Mol Cell Biol       Date:  2010-03-29       Impact factor: 4.272

2.  The design and delivery of a thermally responsive peptide to inhibit S100B-mediated neurodegeneration.

Authors:  S M Hearst; L R Walker; Q Shao; M Lopez; D Raucher; P J S Vig
Journal:  Neuroscience       Date:  2011-09-17       Impact factor: 3.590

3.  Small Molecule Inhibitors of Ca(2+)-S100B Reveal Two Protein Conformations.

Authors:  Michael C Cavalier; Mohd Imran Ansari; Adam D Pierce; Paul T Wilder; Laura E McKnight; E Prabhu Raman; David B Neau; Padmavani Bezawada; Milad J Alasady; Thomas H Charpentier; Kristen M Varney; Eric A Toth; Alexander D MacKerell; Andrew Coop; David J Weber
Journal:  J Med Chem       Date:  2016-01-13       Impact factor: 7.446

4.  S100A1 binds to the calmodulin-binding site of ryanodine receptor and modulates skeletal muscle excitation-contraction coupling.

Authors:  Benjamin L Prosser; Nathan T Wright; Erick O Hernãndez-Ochoa; Kristen M Varney; Yewei Liu; Rotimi O Olojo; Danna B Zimmer; David J Weber; Martin F Schneider
Journal:  J Biol Chem       Date:  2007-12-17       Impact factor: 5.157

5.  Members of the S100 family bind p53 in two distinct ways.

Authors:  Maria Rosario Fernandez-Fernandez; Trevor J Rutherford; Alan R Fersht
Journal:  Protein Sci       Date:  2008-08-11       Impact factor: 6.725

6.  Crystal structure of metastasis-associated protein S100A4 in the active calcium-bound form.

Authors:  Puja Pathuri; Lutz Vogeley; Hartmut Luecke
Journal:  J Mol Biol       Date:  2008-05-07       Impact factor: 5.469

7.  Theoretical study on binding of S100B protein.

Authors:  Artur Gieldon; Mattia Mori; Rebecca Del Conte
Journal:  J Mol Model       Date:  2007-08-23       Impact factor: 1.810

Review 8.  The evolution of S100B inhibitors for the treatment of malignant melanoma.

Authors:  Kira G Hartman; Laura E McKnight; Melissa A Liriano; David J Weber
Journal:  Future Med Chem       Date:  2013-01       Impact factor: 3.808

9.  S100B protein in tissue development, repair and regeneration.

Authors:  Guglielmo Sorci; Francesca Riuzzi; Cataldo Arcuri; Claudia Tubaro; Roberta Bianchi; Ileana Giambanco; Rosario Donato
Journal:  World J Biol Chem       Date:  2013-02-26

10.  The effects of CapZ peptide (TRTK-12) binding to S100B-Ca2+ as examined by NMR and X-ray crystallography.

Authors:  Thomas H Charpentier; Laura E Thompson; Melissa A Liriano; Kristen M Varney; Paul T Wilder; Edwin Pozharski; Eric A Toth; David J Weber
Journal:  J Mol Biol       Date:  2010-01-04       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.